EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma

Jeremy Mo, Anne Zaremba, Andrisha-Jade Inderjeeth, Perla El Zeinaty, Ao Li, Alexandre Wicky, Nicholas Della Marta, Caroline Gaudy-Marqueste, Ann-Sophie Bohne, Margarida Matias, Nicholas McNamee, Lucia Festino und 21 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115254 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Jeremy Mo und 32 weiteren Autor:innen. Beteiligte Einrichtung: Westmead Hospital, Westmead, Australia. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Skin Neoplasms, Immune Checkpoint Inhibitors, B7-H1 Antigen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Health and Medical Research Council, University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Merkel CellSkin NeoplasmsImmune Checkpoint InhibitorsB7-H1 AntigenHumansMaleFemaleAgedRetrospective StudiesMiddle AgedAged, 80 and overDisease ProgressionTreatment OutcomeAdultProgression-Free SurvivalAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

CarcinomaImmune Checkpoint InhibitorsImmunotherapyMerkel CellNeoplasmsSkin

Substanzen

Immune Checkpoint InhibitorsB7-H1 AntigenCD274 protein, humanAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Westmead Hospital, Westmead, Australia.
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Sir Charles Gairdner Hospital, Nedlands, Western Australia; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Université Paris Cité, AP-HP Dermato-Oncology Paris France.
  • Princess Alexandra Hospital, Brisbane, Australia.
  • Lausanne University Hospital, Lausanne, Switzerland.

Förderung

  • National Health and Medical Research Council
  • University of Sydney

Zitieren

APA

Mo, J., Zaremba, A., Inderjeeth, A. J., El Zeinaty, P., Li, A., Wicky, A., Della Marta, N., Gaudy-Marqueste, C., Bohne, A. S., Matias, M., McNamee, N., Festino, L., Chen, C., Ch'ng, S., van Akkooi, A. C. J., Meda, L. D., Park, J. J., Ascierto, P. A., Hauschild, A., …, & da Silva, I. P. (2025). Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115254

Vancouver

Mo J, Zaremba A, Inderjeeth AJ, El Zeinaty P, Li A, Wicky A, et al. Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115254

BibTeX
@article{Mo2025,
  author = {Mo, Jeremy and Zaremba, Anne and Inderjeeth, Andrisha-Jade and El Zeinaty, Perla and Li, Ao and Wicky, Alexandre and Della Marta, Nicholas and Gaudy-Marqueste, Caroline and Bohne, Ann-Sophie and Matias, Margarida and McNamee, Nicholas and Festino, Lucia and Chen, Charley and Ch'ng, Sydney and van Akkooi, Alexander C J and Meda, Laetitia Da and Park, John J and Ascierto, Paolo A and Hauschild, Axel and Lee, Jenny H and Grob, Jean Jacques and Mangana, Joanna and Guminski, Alex and Michielin, Olivier and Xu, Wen and Lebbe, Celeste and Sandhu, Shahneen and Zimmer, Lisa and Menzies, Alexander M and Lo, Serigne N and Long, Georgina V and Carlino, Matteo S and da Silva, Ines Pires},
  title = {Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115254}
}
Kostenlos starten →